• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中的感染——临床医生概述

Infection in Chronic Kidney Disease-An Overview for Clinicians.

作者信息

Dudzicz Sylwia, Wiecek Andrzej, Adamczak Marcin

机构信息

Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, 40-027 Katowice, Poland.

出版信息

J Clin Med. 2021 Jan 7;10(2):196. doi: 10.3390/jcm10020196.

DOI:10.3390/jcm10020196
PMID:33430465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7827228/
Abstract

Increased incidence of infection (CDI), occurrence of severe and complicated CDI, and more frequent occurrence of drug-resistant, recurrent or non-hospital CDI has become a worldwide clinical problem. CDI is more common in patients with chronic kidney disease (CKD) than in the general population. CDI seems to be associated with frequent hospitalization, frequently used antibiotic therapy, dysbiosis, and abnormalities of the immune system observed in CKD patients. Dysbiosis is a common disorder found in CKD patients. It may be related to insufficient fiber content in the diet, reduced amount of consumed fluids and often reduced physical activity, constipation, impaired gastrointestinal motility, multidrug pharmacotherapy, and uremic milieu in CKD stage 5. In patients with CKD the clinical manifestations of CDI are similar to the general population; however, more frequent recurrence of CDI and higher prevalence of severe CDI are reported. Moreover, the increase in CDI related mortality is observed more in CKD patients than in the general population. The aim of this review paper is to summarize the current knowledge concerning the epidemiology, pathogenesis, clinical picture, and prevention and treatment in CKD patients.

摘要

艰难梭菌感染(CDI)发病率上升、严重及复杂性CDI的出现,以及耐药、复发性或非医院获得性CDI的更频繁发生已成为一个全球性的临床问题。CDI在慢性肾脏病(CKD)患者中比在普通人群中更为常见。CDI似乎与CKD患者频繁住院、频繁使用抗生素治疗、生态失调以及免疫系统异常有关。生态失调是CKD患者中常见的病症。它可能与饮食中纤维含量不足、液体摄入量减少、身体活动常常减少、便秘、胃肠动力受损、多药药物治疗以及CKD 5期的尿毒症环境有关。在CKD患者中,CDI的临床表现与普通人群相似;然而,据报道CDI更频繁复发且严重CDI的患病率更高。此外,观察到CDI相关死亡率在CKD患者中比在普通人群中增加得更多。这篇综述文章的目的是总结目前关于CKD患者的流行病学、发病机制、临床表现以及预防和治疗的知识。

相似文献

1
Infection in Chronic Kidney Disease-An Overview for Clinicians.慢性肾脏病中的感染——临床医生概述
J Clin Med. 2021 Jan 7;10(2):196. doi: 10.3390/jcm10020196.
2
The Role of Probiotics in the Prevention of Infection in Patients with Chronic Kidney Disease.益生菌在慢性肾脏病患者感染预防中的作用
Nutrients. 2024 Feb 27;16(5):671. doi: 10.3390/nu16050671.
3
The role of the gut microbiome in colonization resistance and recurrent infection.肠道微生物群在定植抗性和反复感染中的作用。
Therap Adv Gastroenterol. 2022 Nov 18;15:17562848221134396. doi: 10.1177/17562848221134396. eCollection 2022.
4
Clostridioides difficile Infection in Patients with Chronic Kidney Disease: A Systematic Review.艰难梭菌感染与慢性肾脏病:系统综述。
Biomed Res Int. 2021 Sep 13;2021:5466656. doi: 10.1155/2021/5466656. eCollection 2021.
5
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.RBX2660 在 PUNCH CD3 中的疗效和安全性:一项 III 期、随机、双盲、安慰剂对照试验,采用贝叶斯主要分析预防复发性艰难梭菌感染。
Drugs. 2022 Oct;82(15):1527-1538. doi: 10.1007/s40265-022-01797-x. Epub 2022 Oct 26.
6
Clinical Determinants Predicting Infection among Patients with Chronic Kidney Disease.预测慢性肾病患者感染的临床决定因素
Antibiotics (Basel). 2022 Jun 8;11(6):785. doi: 10.3390/antibiotics11060785.
7
The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.布拉氏酵母菌预防治疗对频繁使用易致艰难梭菌感染抗生素的住院患者艰难梭菌医院感染发病率的影响。
Clin Infect Dis. 2021 Nov 2;73(9):e2512-e2518. doi: 10.1093/cid/ciaa808.
8
Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease.艰难梭菌感染与慢性肾脏病/终末期肾病。
Adv Chronic Kidney Dis. 2019 Jan;26(1):30-34. doi: 10.1053/j.ackd.2019.01.001.
9
Is Increased BMI a Risk Factor for Developing Severe Clostridioides Difficile Infection? A Retrospective Study.体重指数增加是发生严重艰难梭菌感染的危险因素吗?一项回顾性研究。
J Community Hosp Intern Med Perspect. 2022 Nov 7;12(6):43-50. doi: 10.55729/2000-9666.1123. eCollection 2022.
10
Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection.晚期慢性肾脏病:艰难梭菌感染的一个强风险因素。
Korean J Intern Med. 2016 Jan;31(1):125-33. doi: 10.3904/kjim.2016.31.1.125. Epub 2015 Dec 28.

引用本文的文献

1
Chronic Kidney Disease as a Predictor of Mortality in Hospitalized Inflammatory Bowel Disease Patients With Clostridioides difficile Infection.慢性肾脏病作为艰难梭菌感染的住院炎症性肠病患者死亡率的预测因素
Cureus. 2025 Jul 16;17(7):e88113. doi: 10.7759/cureus.88113. eCollection 2025 Jul.
2
The role of the intestinal microbiome in cognitive decline in patients with kidney disease.肠道微生物群在肾病患者认知功能衰退中的作用。
Nephrol Dial Transplant. 2025 Mar 13;40(Supplement_2):ii4-ii17. doi: 10.1093/ndt/gfae253.
3
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National Survey.临床和药理学参数对艰难梭菌感染患者粪便微生物群移植结局的影响:一项为期5年的法国全国性调查结果
Aliment Pharmacol Ther. 2025 Jan;61(1):159-167. doi: 10.1111/apt.18330. Epub 2024 Oct 10.
4
The Role of Probiotics in the Prevention of Infection in Patients with Chronic Kidney Disease.益生菌在慢性肾脏病患者感染预防中的作用
Nutrients. 2024 Feb 27;16(5):671. doi: 10.3390/nu16050671.
5
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.感染:历史、流行病学、风险因素、预防、临床表现、治疗和未来选择。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29.
6
A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States.美国艰难梭菌感染的危险因素及发生时间的系统文献综述
Infect Dis Ther. 2024 Feb;13(2):273-298. doi: 10.1007/s40121-024-00919-0. Epub 2024 Feb 13.
7
Clinical Determinants Predicting Infection among Patients with Chronic Kidney Disease.预测慢性肾病患者感染的临床决定因素
Antibiotics (Basel). 2022 Jun 8;11(6):785. doi: 10.3390/antibiotics11060785.

本文引用的文献

1
Trends in U.S. Burden of Infection and Outcomes.美国感染负担和结局的趋势。
N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215.
2
Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges.腹膜透析患者艰难梭菌相关性腹膜炎——基于病例系列的对一种未被充分认识且存在治疗挑战的疾病的综述
BMC Nephrol. 2020 Mar 4;21(1):76. doi: 10.1186/s12882-020-01734-8.
3
: diagnosis and treatments.诊断和治疗。
BMJ. 2019 Aug 20;366:l4609. doi: 10.1136/bmj.l4609.
4
Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review.慢性肾脏病患者的胃肠道微生物群:系统评价。
Adv Nutr. 2019 Sep 1;10(5):888-901. doi: 10.1093/advances/nmz028.
5
Current and future trends in clostridioides (clostridium) difficile infection management.艰难梭菌(梭状芽孢杆菌)感染管理的当前和未来趋势。
Anaerobe. 2019 Aug;58:95-102. doi: 10.1016/j.anaerobe.2019.04.010. Epub 2019 May 1.
6
Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease.艰难梭菌感染与慢性肾脏病/终末期肾病。
Adv Chronic Kidney Dis. 2019 Jan;26(1):30-34. doi: 10.1053/j.ackd.2019.01.001.
7
Probiotics, prebiotics and amelioration of diseases.益生菌、益生元和疾病改善。
J Biomed Sci. 2019 Jan 4;26(1):3. doi: 10.1186/s12929-018-0493-6.
8
Reduces the Incidence of Infection in Nephrology and Transplantation Ward-Results of One Year Extended Study.减少肾病和移植病房感染发生率——一年延伸研究结果。
Nutrients. 2018 Oct 24;10(11):1574. doi: 10.3390/nu10111574.
9
Peritonitis: An Emerging Infection in Peritoneal Dialysis Patients.腹膜炎:腹膜透析患者中一种新出现的感染
Case Rep Med. 2018 Sep 19;2018:3537283. doi: 10.1155/2018/3537283. eCollection 2018.
10
Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature.实体器官移植患者复发性艰难梭菌感染的粪便微生物群移植:机构经验及文献综述
Transpl Infect Dis. 2018 Dec;20(6):e12967. doi: 10.1111/tid.12967. Epub 2018 Jul 31.